{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:31:38Z","timestamp":1787895098375,"version":"build-2784847793"},"reference-count":21,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>We present the case of a 70-year-old man with a history of haemophilia B, who presented to our hospital with a non-ST-elevation myocardial infarction. The patient, following consultation by a haemophilia expert, was revascularized with percutaneous coronary intervention (PCI) under adequate clotting factor administration. Patients with haemophilia and acute coronary syndrome, are susceptible to periprocedural bleeding and thrombotic events during PCI, and therefore a balanced management plan should always be implemented by a multidisciplinary team.<\/jats:p>","DOI":"10.3390\/medicina57040352","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T03:52:03Z","timestamp":1617767523000},"page":"352","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["How to Manage a Patient with Haemophilia and ACS Requiring PCI: A Battle between Bleeding and Thrombosis"],"prefix":"10.3390","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-121X","authenticated-orcid":false,"given":"Konstantinos C.","family":"Theodoropoulos","sequence":"first","affiliation":[{"name":"Second Cardiology Department, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"},{"name":"First Cardiology Department, University General Hospital AHEPA, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Vakalopoulou","sequence":"additional","affiliation":[{"name":"Haemophilia Centre of Northern Greece, Second Propaedeutic Department of Internal Medicine, Medical School, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Oikonomou","sequence":"additional","affiliation":[{"name":"Second Cardiology Department, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Stavropoulos","sequence":"additional","affiliation":[{"name":"Second Cardiology Department, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Ziakas","sequence":"additional","affiliation":[{"name":"First Cardiology Department, University General Hospital AHEPA, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kanonidis","sequence":"additional","affiliation":[{"name":"Second Cardiology Department, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kassimis","sequence":"additional","affiliation":[{"name":"Second Cardiology Department, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e005375","DOI":"10.1161\/CIRCOUTCOMES.118.005375","article-title":"Mortality From Ischemic Heart Disease","volume":"12","author":"Nowbar","year":"2019","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_2","first-page":"e344","article-title":"ACC\/AHA Task Force Members; Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Collet, J.P., Thiele, H., Barbato, E., Barth\u00e9l\u00e9my, O., Bauersachs, J., Bhatt, D.L., Dendale, P., Dorobantu, M., Edvardsen, T., and Folliguet, T. (2020). ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J., ehaa575.","DOI":"10.15829\/1560-4071-2021-4418"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: Appropriateness of including bleeding as a component of a quadruple end point","volume":"5","author":"Ndrepepa","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jth.12317","article-title":"Hemophilia A and hemophilia B: Focus on arthropathy and variables affecting bleeding severity and prophylaxis","volume":"11","author":"Escobar","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bmj.2.4799.1378","article-title":"Christmas disease: A condition previously mistaken for haemophilia","volume":"2","author":"Biggs","year":"1952","journal-title":"Br. Med. J."},{"key":"ref_7","first-page":"19351939","article-title":"Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Definitions in hemophilia: Communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/2040620712440007","article-title":"New treatments in hemophilia: Insights for the clinician","volume":"3","author":"Knobe","year":"2012","journal-title":"Ther. Adv. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood-2013-11-453159","article-title":"Cardiovascular risk in patients with hemophilia","volume":"123","author":"Kamphuisen","year":"2014","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1538-7836.2008.03201.x","article-title":"Cardiovascular disease in patients with hemophilia","volume":"7","author":"Tuinenburg","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/hae.12189","article-title":"Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia\u2014An assessment by the ADVANCE Working Group","volume":"19","author":"Staritz","year":"2013","journal-title":"Haemophilia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11239-012-0802-y","article-title":"Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: An interventional dilemma: Case series, review of the literature, and tips for management","volume":"35","author":"Fefer","year":"2013","journal-title":"J. Thromb. Thrombolysis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"33723375","DOI":"10.1093\/eurheartj\/ehw215","article-title":"Is it time to take bare metal stents off the catheter laboratory shelf?","volume":"37","author":"Kassimis","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","article-title":"Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates","volume":"65","author":"Valgimigli","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(17)32713-7","article-title":"Drugeluting stents in elderly patients with coronary artery disease (SENIOR): A randomised single-blind trial","volume":"391","author":"Varenne","year":"2018","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk","volume":"373","author":"Urban","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1910021","article-title":"Polymerbased or Polymer-free Stents in Patients at High Bleeding Risk","volume":"382","author":"Windecker","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2015-12-635094","article-title":"How I treat patients with inherited bleeding disorders who need anticoagulant therapy","volume":"128","author":"Martin","year":"2016","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ccd.27255","article-title":"Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review","volume":"92","author":"Boehnel","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0040-1718410","article-title":"Long-Term An tithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry","volume":"121","author":"Guillet","year":"2021","journal-title":"Thromb. Haemost."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/4\/352\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:58:44Z","timestamp":1760363924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/4\/352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["medicina57040352"],"URL":"https:\/\/doi.org\/10.3390\/medicina57040352","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]}}}